ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.523,22
0,57%
S&P 500
5.291,34
0,15%
Dow Jones
38.711,29
0,36%
Euro vs US Dollar
1,08725
-0,08%
Bitcoin
71.076,24
0,64%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. 10x Genomics Inc (TXG)

  7. 10x Genomics Inc (TXG) News

TXG

10x Genomics (TXG)

10x Genomics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TXG
DatumZeitQuelleÜberschriftSymbolFirma
31/05/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
29/05/202422h05PR Newswire (US)10x Genomics Launches 5,000-Plex Gene Panel for XeniumNASDAQ:TXG10x Genomics Inc
24/05/202401h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
24/05/202401h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
24/05/202401h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
22/05/202422h27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
22/05/202422h23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
22/05/202422h17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
02/05/202422h05PR Newswire (US)10x Genomics to Present at the BofA Securities 2024 Healthcare ConferenceNASDAQ:TXG10x Genomics Inc
30/04/202422h05PR Newswire (US)10x Genomics Reports First Quarter 2024 Financial ResultsNASDAQ:TXG10x Genomics Inc
10/04/202422h05PR Newswire (US)10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024NASDAQ:TXG10x Genomics Inc
26/03/202414h00PR Newswire (US)10x Genomics Commercially Launches Visium HD Spatial Gene Expression AssayNASDAQ:TXG10x Genomics Inc
21/03/202421h05PR Newswire (US)10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene PanelNASDAQ:TXG10x Genomics Inc
13/03/202421h05PR Newswire (US)10x Genomics Begins Commercial Shipments of Chromium GEM-X ProductsNASDAQ:TXG10x Genomics Inc
06/03/202422h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
05/03/202400h40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
26/02/202422h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
26/02/202422h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
26/02/202422h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
23/02/202401h19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
23/02/202401h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
23/02/202400h59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
20/02/202422h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
20/02/202422h05PR Newswire (US)10x Genomics to Present at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:TXG10x Genomics Inc
15/02/202423h33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TXG10x Genomics Inc
15/02/202423h16Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TXG10x Genomics Inc
15/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
15/02/202422h05PR Newswire (US)10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024NASDAQ:TXG10x Genomics Inc
13/02/202422h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
07/02/202422h05PR Newswire (US)10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X TechnologyNASDAQ:TXG10x Genomics Inc
 Showing the most relevant articles for your search:NASDAQ:TXG

Kürzlich von Ihnen besucht

COIN
SAXUSD
SOLA-X
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten